Literature DB >> 18668339

Early-life events may trigger biochemical pathways for Alzheimer's disease: the "LEARn" model.

Debomoy K Lahiri1, Nasser H Zawia, Nigel H Greig, Kumar Sambamurti, Bryan Maloney.   

Abstract

Alzheimer's disease (AD), the most common form of dementia among the elderly, manifests mostly late in adult life. However, it is presently unclear when the disease process starts and how long the pathobiochemical processes take to develop. Our goal is to address the timing and nature of triggers that lead to AD. To explain the etiology of AD, we have recently proposed a "Latent Early-life Associated Regulation" (LEARn) model, which postulates a latent expression of specific genes triggered at the developmental stage. This model integrates both the neuropathological features (e.g., amyloid-loaded plaques and tau-laden tangles) and environmental factors (e.g., diet, metal exposure, and hormones) associated with the disease. Environmental agents perturb gene regulation in a long-term fashion, beginning at early developmental stages, but these perturbations do not have pathological results until significantly later in life. The LEARn model operates through the regulatory region (promoter) of the gene and by affecting the methylation status within the promoter of specific genes.

Entities:  

Mesh:

Year:  2008        PMID: 18668339      PMCID: PMC4841617          DOI: 10.1007/s10522-008-9162-6

Source DB:  PubMed          Journal:  Biogerontology        ISSN: 1389-5729            Impact factor:   4.277


  13 in total

1.  Characterization of two APP gene promoter polymorphisms that appear to influence risk of late-onset Alzheimer's disease.

Authors:  Debomoy K Lahiri; Yuan-Wen Ge; Bryan Maloney; Fabienne Wavrant-De Vrièze; John Hardy
Journal:  Neurobiol Aging       Date:  2004-12-22       Impact factor: 4.673

2.  Supplementation with apple juice attenuates presenilin-1 overexpression during dietary and genetically-induced oxidative stress.

Authors:  Amy Chan; Thomas B Shea
Journal:  J Alzheimers Dis       Date:  2006-12       Impact factor: 4.472

3.  Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer's disease.

Authors:  Bryan Maloney; Yuan-Wen Ge; George M Alley; Debomoy K Lahiri
Journal:  J Neurochem       Date:  2007-09-08       Impact factor: 5.372

Review 4.  How and when environmental agents and dietary factors affect the course of Alzheimer's disease: the "LEARn" model (latent early-life associated regulation) may explain the triggering of AD.

Authors:  Debomoy K Lahiri; Bryan Maloney; Md Riyaz Basha; Yuan Wen Ge; Nasser H Zawia
Journal:  Curr Alzheimer Res       Date:  2007-04       Impact factor: 3.498

5.  The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain.

Authors:  M Riyaz Basha; Wei Wei; Saleh A Bakheet; Nathalie Benitez; Hasan K Siddiqi; Yuan-Wen Ge; Debomoy K Lahiri; Nasser H Zawia
Journal:  J Neurosci       Date:  2005-01-26       Impact factor: 6.167

6.  Exposure to lead and the developmental origin of oxidative DNA damage in the aging brain.

Authors:  Celeste M Bolin; Riyaz Basha; David Cox; Nasser H Zawia; Bryan Maloney; Debomoy K Lahiri; Fernando Cardozo-Pelaez
Journal:  FASEB J       Date:  2006-02-16       Impact factor: 5.191

7.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08

8.  Dietary supplementation with melatonin reduces levels of amyloid beta-peptides in the murine cerebral cortex.

Authors:  Debomoy K Lahiri; Demao Chen; Yuan-Wen Ge; Stephen C Bondy; Edward H Sharman
Journal:  J Pineal Res       Date:  2004-05       Impact factor: 13.007

Review 9.  A partial failure of membrane protein turnover may cause Alzheimer's disease: a new hypothesis.

Authors:  Kumar Sambamurti; Anitha Suram; Chitra Venugopal; Annamalai Prakasam; Yan Zhou; Debomoy K Lahiri; Nigel H Greig
Journal:  Curr Alzheimer Res       Date:  2006-02       Impact factor: 3.498

10.  Copper depletion down-regulates expression of the Alzheimer's disease amyloid-beta precursor protein gene.

Authors:  Shayne A Bellingham; Debomoy K Lahiri; Bryan Maloney; Sharon La Fontaine; Gerd Multhaup; James Camakaris
Journal:  J Biol Chem       Date:  2004-02-25       Impact factor: 5.157

View more
  26 in total

Review 1.  Neuronutrition and Alzheimer's disease.

Authors:  Balenahalli N Ramesh; T S Sathyanarayana Rao; Annamalai Prakasam; Kumar Sambamurti; K S Jagannatha Rao
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of AβPP transgenic mice.

Authors:  Jin Yu; Marco Gattoni-Celli; Hong Zhu; Narayan R Bhat; Kumar Sambamurti; Sebastiano Gattoni-Celli; Mark S Kindy
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

3.  Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease.

Authors:  Robert J Baranello; Krishna L Bharani; Vasudevaraju Padmaraju; Nipun Chopra; Debomoy K Lahiri; Nigel H Greig; Miguel A Pappolla; Kumar Sambamurti
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

4.  Targets for AD treatment: conflicting messages from γ-secretase inhibitors.

Authors:  Kumar Sambamurti; Nigel H Greig; Tadanobu Utsuki; Eliza L Barnwell; Ekta Sharma; Cheryl Mazell; Narayan R Bhat; Mark S Kindy; Debomoy K Lahiri; Miguel A Pappolla
Journal:  J Neurochem       Date:  2011-03-15       Impact factor: 5.372

Review 5.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

Review 6.  Pharmacology of epigenetics in brain disorders.

Authors:  Pritika Narayan; Mike Dragunow
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

7.  The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases.

Authors:  D K Lahiri; B Maloney; N H Zawia
Journal:  Mol Psychiatry       Date:  2009-11       Impact factor: 15.992

8.  The "LEARn" (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer's disease, and proposes remedial steps.

Authors:  Debomoy K Lahiri; Bryan Maloney
Journal:  Exp Gerontol       Date:  2010-01-11       Impact factor: 4.032

Review 9.  Epigenetics: a novel therapeutic approach for the treatment of Alzheimer's disease.

Authors:  Lina Adwan; Nasser H Zawia
Journal:  Pharmacol Ther       Date:  2013-04-03       Impact factor: 12.310

10.  Nutritional contributions to dementia prevention: main issues on antioxidant micronutrients.

Authors:  Maria Cristina Polidori; Ralf-Joachim Schulz
Journal:  Genes Nutr       Date:  2014-02-18       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.